MADHU DEWAN KHATRI: Open Payments
NPI 1891434841 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 39 payments from 21 companies in 2025. Trend: 2023 $2,612 · 2024 $2,403 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 4 | $238 |
| Amgen Inc. | 8 | $197 |
| Ascendis Pharma Endocrinology Inc | 2 | $148 |
| Neurocrine BioSciences, Inc. | 1 | $133 |
| BETA BIONICS, INC. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Soleno Therapeutics, Inc. | 2 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
| Madrigal Pharmaceuticals | 1 | $48 |
| Mannkind Corporation | 2 | $40 |
Products named: Omnipod, Yorvipath, CRENESSITY, iLet Bionic Pancreas, EVENITY, TEPEZZA, JARDIANCE, VYKAT XR.
Industry payments across NV — which companies pay providers there.
